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INTRODUCTION
Cystic fibrosis (CF; MIM 219700) is a lethal disease, which
is induced by mutations in the cystic fibrosis transmembrane
conductance regulator (CFTR) gene on chromosome 7q31.
CF is one of the most frequently-occurring autosomal reces-
sive disorders in Caucasians, with an incidence of 1 in every
2,000 to 3,000 (1). However, CF is quite rare in the Asian
population that an epidemiological study in the Japanese
population revealed the incidence of CF being about 1 in
350,000 (2, 3). CF is also extremely rare in the Korean pop-
ulation and there have been only a few reports of this condi-
tion thus far (4-6). Here, we report a Korean patient with
CF, who was diagnosed by both a sweat chloride test and
genetic analysis of the CFTR gene.
CASE REPORT
A 15-yr-old boy was admitted to the Samsung Medical
Center, complaining of chronic productive cough and dysp-
nea without any gastrointestinal symptoms. During the first
decades of life, the patient had been treated for several episodes
of bronchiolitis and pneumonia, necessitating frequent hos-
pital admission. Six years prior to the current hospitalization,
the patient’s respiratory symptoms became aggravated. He
was admitted to a civil hospital for the treatment of pulmonary
tuberculosis, and received antituberculosis drug therapy for
12 months. He developed frequent rhinorrhea and nasal stuffi-
ness, and underwent sinus surgery at the age of twelve. His
respiratory symptoms progressively worsened, and he was
diagnosed with bronchiectasis three years ago. He had a 25-
yr-old brother and a 24-yr-old sister, with an unremarkable
past and a current medical history.
On admission, the patient’s blood pressure was 128/69
mmHg, heart rate 80 beats per minute, respiratory rate 20
breaths per minute, body temperature 36.0℃, height 174
cm, and he weighed 53.6 kg. He was also determined to
exhibit 96 percent oxygen saturation when breathing room
air. Upon physical examination, diffuse crackles and rhonchi
were heard throughout the patient’s lungs, with intermittent
wheezes.
Chest radiographs and computed tomographic (CT) scans
of the chest, performed without intravenous contrast mate-
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Report of a Korean Patient with Cystic Fibrosis, Carrying Q98R and
Q220X Mutations in the CFTR Gene
Although cystic fibrosis (CF) is one of the most frequently seen autosomal-reces-
sive disorders in Caucasians, it is extremely rare in the Korean population. Recently,
a 15-yr-old Korean boy was admitted to our hospital complaining of coughing, spu-
tum, and exertional dyspnea. Chest radiographs and computed tomographic chest
and paranasal sinus scans revealed diffuse bronchiectasis and pansinusitis. Pul-
monary function tests revealed severe obstructive impairment. The average sweat
chloride concentrations on both of the patients’ forearms were 63.0 mM/L (reference
limit: <40 mM/L). Upon mutation analysis, two different mutations (Q98R and Q220X)
were identified in the cystic fibrosis transmembrane conductance regulator gene,
both of which had been previously detected in CF patients, one from France and
the other from England. As CF is quite rare in Korea, the diagnosis of CF in this
patient might be delayed. Therefore, we recommend that a diagnosis of CF should
be suspected in patients exhibiting unexplained chronic respiratory symptoms.
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rial administration, revealed bilateral multifocal bronchiec-
tasis and multiple centrilobular nodules (Fig. 1). Pulmonary
function studies showed a forced vital capacity of 2.62 L (63%
of predicted), with a forced expiratory volume of 1.36 L per
second (36% of predicted). The patient’s total lung capacity
was measured to be 6.39 L (121% of predicted). A CT scan
of his paranasal sinuses evidenced severe inflammatory changes,
associated with pansinusitis. Staphylococcus aureus was cultured
from his sputum. Mycobacterial and fungal cultures were
negative. A tuberculin skin test was also negative. Condi-
tions such as immunodeficiency and ciliary dyskinesia were
ruled out by the normal results of serum immunoglobulin
tests, and by the finding of normal bronchial mucosal biop-
sy. There was no evidence of exocrine pancreatic insufficien-
cy and malaborption.
The sweat chloride concentration was measured by a quan-
titative pilocarpine iontophoresis sweat test, in accordance
with the guidelines of the National Committee for Clinical
Laboratory Standards (7). The average sweat chloride concen-
trations on both forearms were 63.0 mM/L, a finding that
exceeded the reference limit (<40 mM/L).
Direct sequencing analysis of all coding exons and their
flanking intronic sequences demonstrated that the patient
possessed two mutations in his CFTR gene (Fig. 2): a het-
erozygous A to G transition in exon 4 (c.293A>G; Q98R)
and a heterozygous C to T transition in exon 6a (c.658C>T;
Q220X). A family study demonstrated that the patient’s
father and elder brother both also possessed the Q98R muta-
tion, whereas his mother harbored the Q220X mutation.
The patient’s sister, however, harbored no such mutations.
Based on our search of the Cystic Fibrosis Mutation Database
(http://www.genet.sickkids.on.ca/cftr/), Q98R and Q220X
mutations have been reported in CF patients from Southern
France and Southern England (8, 9).
DISCUSSION
CF is the most frequently encountered life-limiting auto-
somal recessive genetic disorder in Caucasians, with an inci-
Fig. 1. Chest plain radiograph shows diffuse reticulonodular densities in both central lung areas with symmetricity (A). A tram tract sign is
noted in right middle lung zone, representing bronchiectasis. On computed tomographic image with lung window setting, diffuse bronchiec-
tasis and bronchiolectasis are seen in both lungs with ill-defined small centrilobular nodules, representing associated bronchiolitis. Under-





Fig. 2. Pedigree of a Korean family with cystic fibrosis. A heterozy-
gous Q98R mutation is found in the father, brother, and the proband,
and another heterozygous Q220X mutation is found in the mother
and the proband. Squares indicate males, circles indicate females,
and an arrow indicates the proband. Open symbols with or with-
out central dot indicate carriers and an unaffected family mem-
ber, respectively, and a darkened symbol indicates an affected
family member.Cystic Fibrosis with CFTR Gene Mutations 565
dence of 1 in every 3,200 newborns in the United States (1).
However, it is less common in African Americans (1 in
15,000) (10) and quite rare in Asians (1 in 350,000 in the
Japanese population) (2, 3). CF is normally suspected upon
the finding of one or more typical CF phenotypical features,
including chronic sinopulmonary disease, gastrointestinal/
nutritional abnormalities, salt loss syndrome, and obstruc-
tive azoospermia in males (7).
CF is caused by mutations in the CFTR gene, which is
located on the long arm of chromosome 7. This gene consists
of 27 exons, and encodes for an integral membrane protein
composed of 1,480 amino acids. Functionally, CFTR regu-
lates the expression of the chloride (Cl
-) channel, which is
expressed in the apical membrane of exocrine epithelial cells
(1). Currently, approximately 1,366 mutations and polymor-
phisms are listed in the Cystic Fibrosis Mutation Database
(http://www.genet.sickkids.on.ca/cftr/). However, only 11
mutations have been reported in the Korean population thus
far (Table 1). In the present study, we report two additional
mutations in the list of CFTR gene mutations (Q98R and
Q220X), which have been identified in Koreans. It is of note
that these two mutations have previously been reported in
CF patients from Southern France (8) and Southern England
(9), respectively, but are not frequently encountered muta-
tions even in the Caucasian population.
As shown in the Table, no mutation except IVS8 T5 vari-
ant has repeatedly been observed in Korean population. Fur-
thermore, only two mutations (R117H and delF508) are
found among 25 mutations in the screening panel for Cau-
casian CF patients recommended by the American College
of Medical Genetics (11). Therefore, as demonstrated by Lee
et al. (12), a possible common mutation might not exist in
the Korean population.
Although CF tends to be discovered early in life, the diagno-
sis of CF is being made in adults with increased frequency
(13, 14). Patients diagnosed as adults normally present with
chronic respiratory problems. As a group, they exhibit a milder
variant of lung disease, a lesser degree of Pseudomonas infection,
and are more likely to be pancreatic-sufficient than are patients
in whom CF is diagnosed at earlier ages (13, 14). Physicians
who are unfamiliar with the spectrum of CF phenotypic mani-
festations may not consider CF as a component of their dif-
ferential diagnoses, thus delaying accurate diagnosis.
In summary, we report here a Korean CF patient, who was
diagnosed via a sweat chloride test, as well as a molecular
genetic analysis of the patient’s CFTR gene. Although CF
continues to be quite a rare condition in Koreans, CF should
still be suspected in patients exhibiting recurrent and unex-
plained chronic respiratory symptoms.
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